glottic cancer

声门癌
  • 文章类型: Journal Article
    该研究的目的是利用高速视频喉镜检查(HSV)对声带的振动特性进行定量评估,以诊断声门的良性和恶性病变。
    方法:病例对照研究包括100例单侧声带病变患者,与38例正常声带患者进行比较。通过确定声带振荡参数的定量评估是基于HSVkymography进行的。开发并验证了机器学习预测模型。
    结果:所有计算参数在健康受试者和器质性病变患者之间存在显著差异。区分任何器质性病变患者与健康受试者的第一个预测模型达到等于0.983的曲线下面积(AUC),并以89.3%的准确性呈现。灵敏度为97.0%,和71.4%的特异性测试集。在器质性病变中识别恶性肿瘤的第二个模型达到了等于0.85的AUC,准确率为80.6%。100%灵敏度,训练集上的特异性为71.1%。模型的重要预测因素是频率扰动措施。
    结论:区分良性和恶性病变的标准方案仍然是由经验丰富的耳鼻喉科专家进行临床评估,并通过组织病理学检查证实。我们的发现确实表明,先进的机器学习模型,考虑到HSV数据中存在的复杂相互作用,可能表明恶性肿瘤的风险增加。因此,这项技术在帮助早期癌症检测方面至关重要,从而强调需要进一步调查和验证。
    The aim of the study was to utilize a quantitative assessment of the vibratory characteristics of vocal folds in diagnosing benign and malignant lesions of the glottis using high-speed videolaryngoscopy (HSV).
    METHODS: Case-control study including 100 patients with unilateral vocal fold lesions in comparison to 38 normophonic subjects. Quantitative assessment with the determination of vocal fold oscillation parameters was performed based on HSV kymography. Machine-learning predictive models were developed and validated.
    RESULTS: All calculated parameters differed significantly between healthy subjects and patients with organic lesions. The first predictive model distinguishing any organic lesion patients from healthy subjects reached an area under the curve (AUC) equal to 0.983 and presented with 89.3% accuracy, 97.0% sensitivity, and 71.4% specificity on the testing set. The second model identifying malignancy among organic lesions reached an AUC equal to 0.85 and presented with 80.6% accuracy, 100% sensitivity, and 71.1% specificity on the training set. Important predictive factors for the models were frequency perturbation measures.
    CONCLUSIONS: The standard protocol for distinguishing between benign and malignant lesions continues to be clinical evaluation by an experienced ENT specialist and confirmed by histopathological examination. Our findings did suggest that advanced machine learning models, which consider the complex interactions present in HSV data, could potentially indicate a heightened risk of malignancy. Therefore, this technology could prove pivotal in aiding in early cancer detection, thereby emphasizing the need for further investigation and validation.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Case Reports
    副肿瘤性IgA肾病(IgAN)是一种未被认可的疾病,其中恶性肿瘤表现为IgAN的症状,关于IgAN和恶性肿瘤之间的机制关系仍然存在争议。在这里,我们报告了一例68岁的日本声门型喉癌患者,他发展为肾病综合征作为IgAN的临床表现。肾活检显示弥漫性增生性肾小球肾炎伴肾小球毛细血管IgA沉积,这是一种罕见的IgAN亚型。声门癌通过照射完全缓解后,蛋白尿和血尿消失。根据他的临床课程,我们诊断为副肿瘤IgAN.因此,我们应该考虑伴有肾小球毛细血管IgA沉积的IgAN可能是副肿瘤性肾小球病的可能性,尤其是在开始免疫抑制治疗之前。患者此后发展为前列腺癌和肝细胞癌,但伊根没有复发。在该三重癌症患者中,IgAN与声门癌的特异性关联可能表明IgAN与粘膜癌之间存在潜在的联系。因为观察到半乳糖缺陷型IgA1(Gd-IgA1)与IgA相似,Gd-IgA1也可能在副肿瘤IgAN的发病机制中起重要作用。
    Paraneoplastic IgA nephropathy (IgAN) is an underrecognized condition in which malignancy manifests as symptoms of IgAN, and it remains controversial regarding their mechanistic relation between IgAN and malignancy. Herein, we report a case of a 68-year-old Japanese man with glottic cancer who developed nephrotic syndrome as a clinical manifestation of IgAN. Renal biopsy revealed diffuse proliferative glomerulonephritis with glomerular capillary IgA deposition that is a rare subtype of IgAN. After complete remission of the glottic cancer by irradiation, proteinuria and hematuria disappeared. Based on his clinical course, we diagnosed paraneoplastic IgAN. Therefore, we should consider the possibility that IgAN with glomerular capillary IgA deposition might be paraneoplastic glomerulopathy especially before initiating immunosuppressive therapy. The patient thereafter developed prostate cancer and hepatocellular cancer, but IgAN did not recur. The association of IgAN specifically with the glottic cancer in this triple-cancer patient may suggest a potential link between IgAN and mucosal cancer. Because galactose-deficient IgA1 (Gd-IgA1) was observed in the similar pattern as IgA, Gd-IgA1 also may play an important role in the pathogenesis of paraneoplastic IgAN.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Case Reports
    背景:我们报道了一例因T1a声门鳞状细胞癌接受确定性放疗(RT)后吸烟诱发放射性喉坏死(RLN)的患者。
    方法:患者是一名63岁男性,有大量吸烟史。当他被诊断出患有声门鳞状细胞癌时,他戒烟了。RT剂量为63Gy,用三维常规喉部RT技术分28次递送。RT完成后,最初的治疗反应为完全缓解.然后他接受了后续检查。RT后13个月,病人恢复吸烟。恢复吸烟后2个月,他有严重的喉咙痛和声音嘶哑。喉镜检查显示声门有一个大肿瘤。进行了手术切除,患者在组织学上被诊断为RLN,晚期毒性无癌症复发。术后3周,病人呼吸困难,喉镜检查显示全喉麻痹。因此,他接受了紧急气管切开术。服用类固醇会影响RLN,喉瘫逐渐好转。
    结论:此病例提示吸烟可能在RT后诱发RLN。此外,持续戒烟对于接受RT的声门型喉癌患者非常重要.与其把戒烟留给病人,临床医生有必要积极干预,以帮助患者继续努力戒烟。
    BACKGROUND: We report the case of a patient with smoking-induced radiation laryngeal necrosis (RLN) after undergoing definitive radiotherapy (RT) alone for T1a glottic squamous cell carcinoma.
    METHODS: The patient was a 63-year-old man who had a history of heavy smoking. He quit smoking when he was diagnosed with glottic squamous cell carcinoma. The RT dose was 63 Gy, delivered in 28 fractions with the three-dimensional conventional RT technique for the larynx. After RT completion, the initial treatment response was complete response. He then underwent follow-up examinations. At 13 months after RT, the patient resumed smoking. At 2 months after resuming smoking, he had severe sore throat and hoarseness. Laryngoscopy revealed a large tumor in the glottis. Surgical excision was performed, and the patient was histologically diagnosed with RLN, as late toxicity without cancer recurrence. At 3 weeks postoperatively, the patient had dyspnea, and laryngoscopy revealed total laryngeal paralysis. Thus, he underwent an emergent tracheostomy. The administration of steroids affected RLN, and laryngeal paralysis gradually improved.
    CONCLUSIONS: This case suggests that smoking may have the potential to induce RLN after RT. Moreover, continuing smoking cessation is significantly important for patients with glottic cancer who receive RT. Rather than leaving smoking cessation up to the patient, it would be necessary for clinicians to actively intervene to help patients continue their effort to quit smoking.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Sci-hub)

  • 文章类型: Journal Article
    目的:声门型喉癌TLM后边缘状态的值值得商榷,由于标本定位和边缘分析的困难。为了减少这些困难,我们最近引入了TLM标本定向固定的标准化方案.这被证明是可行的,并导致高边缘可评估率和假阳性深度边缘率降低,与历史TLM队列相比。对于根据此协议处理标本的患者,我们前瞻性分析了肿瘤结果,与历史TLM队列相比,确定预后因素并评估方案引入对结局的影响.
    方法:纳入了接受TLM治疗的96例声门恶性肿瘤患者。根据新方案处理切除标本。描述性统计和生存分析用于确定肿瘤结果。为了评估方案引入对结果的影响,进行了匹配的病例对照分析,使用历史TLM队列作为对照。采用Cox比例风险模型分析患者的预后效果及治疗特点,包括病理学方案介绍,关于总生存期(OS),疾病特异性生存率(DSS),无病生存率(DFS)和无局部复发生存率(LRFS)。
    结果:两年的结果是有利的:88.5%的OS,97.0%DSS,和87.6%的LRFS。在多变量分析中,多个阳性表面边缘的存在是OS的阴性预测因子(HR4.102),而增加的cT分类证明是DFS(HR2.828)和LRFS(HR2.676)的阴性预测因子.匹配的病例对照分析未显示队列之间肿瘤结局的显着差异。深度边缘状态对队列之间的DFS(相互作用的p值=0.0205)和LRFS(相互作用的p值=0.0176)有很强的差异效应,表明深度边缘状态对当前队列中两种结局的预后影响,但不是在历史队列中。
    结论:与历史TLM队列相比,引入一种新的TLM标本定向固定标准化技术并不影响肿瘤结局,但对DFS和LRFS的深度边缘状态具有显著的预后影响,促进关于规划第二眼程序的决策过程,给予辅助放疗或确定随访强度。
    OBJECTIVE: The value of margin status after TLM for glottic cancer is debatable, due to difficulties in specimen orientation and margin analysis. To reduce these difficulties, we recently introduced a standardized protocol of oriented fixation of TLM specimens. This proved feasible and resulted in high margin evaluability rates and a decreased rate of false positive deep margins, when compared to a historical TLM cohort. For the patients whose specimens were processed according to this protocol, we prospectively analyzed oncological outcomes, identified prognostic factors and assessed the influence of the protocol introduction on outcomes compared with a historical TLM cohort.
    METHODS: Ninety-six patients with glottic malignancies treated with TLM were included. Resection specimens were processed according to the new protocol. Descriptive statistics and survival analyses were used to determine oncological outcomes. To assess the effect of the protocol introduction on outcomes, a matched-case-control analysis was performed, using a historical TLM-cohort as controls. The Cox proportional hazards model was used to analyze prognostic effects of patient and treatment characteristics, including the pathology protocol introduction, on overall survival (OS), disease-specific survival (DSS), disease-free survival (DFS) and local recurrence-free survival (LRFS).
    RESULTS: Two-year outcomes were favorable: 88.5% OS, 97.0% DSS, and 87.6% LRFS. At multivariable analysis, the presence of multiple positive superficial margins was a negative prognosticator for OS (HR 4.102) and increasing cT classification proved a negative prognosticator for DFS (HR 2.828) and LRFS (HR 2.676). Matched case-control analysis did not reveal a significant difference in oncological outcomes between cohorts. Deep margin status had a strong differential effect for DFS (p-value for interaction = 0.0205) and for LRFS (p-value for interaction = 0.0176) between cohorts, indicating a prognostic effect of deep margin status on both outcomes in the current cohort, but not in the historical cohort.
    CONCLUSIONS: The introduction of a new standardized technique of oriented fixation of TLM specimens did not affect oncological outcomes when compared to a historical TLM cohort, but assigned a significant prognostic effect to deep margin status for DFS and LRFS, facilitating the decision making process with regards to planning of second-look procedures, administration of adjuvant radiotherapy or determination of follow-up intensity.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Case Reports
    OBJECTIVE: To propose, in patients presenting a difficult laryngeal exposure, a surgical innovation allowing to perform a transoral laser cordectomy for cancers reaching the anterior commissure or the anterior third of vocal folds (according to the European Laryngological Society classification of laryngeal endoscopic cordectomies).
    METHODS: Our surgical technique consisted of adding to conventional cordectomies a modified relaxation thyroplasty proposed by Isshiki (type III), also called relaxation thyroplasty by a medial approach in the European Laryngological Society classification system. The anterior commissure retrusion is usually employed in the management of high-pitched voice disorders, but can also allow a better exposure of the anterior commissure.
    RESULTS: We described here this surgical innovation through the example of our first two patients. For both patients, the definitive histologic analysis showed negative microscopic margins and there was no post-operative complication. There was no need for a tracheostomy. They were allowed to take a normal diet after 2 days and were discharged after 4 days. The voice was breathy and hoarse as expected in case of extended cordectomy.
    CONCLUSIONS: This surgical innovation corresponding to the addition of an anterior commissure retrusion by a bilateral thyrotomy could be useful in the ELS classification of endoscopic cordectomies. It should allow surgeons to carry out a transoral CO2 laser cordectomy in patients with a T1 and sometimes T2 glottic carcinoma, even with a difficult laryngeal exposure.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    本研究的目的是报告一例在声门癌放疗期间患有韦格纳肉芽肿病(WG)的患者发生多发性下颅神经麻痹的罕见病例。WG是一种自身免疫性疾病,其特征是坏死性肉芽肿主要发生在上呼吸道和下呼吸道或肾脏;然而,颅神经受累并不少见。在使用环磷酰胺(CYC)之前,1年死亡率约为82%;利妥昔单抗(RTX)的引入彻底改变了WG的进程,缓解率与CYC相当,复发患者的疗效更好。低丙种球蛋白血症和B细胞耗竭是由于继发感染而影响生存的最著名的监测副作用。免疫抑制和下颅神经麻痹的复发对预后有负面影响。我们在此介绍了严重预处理的GPA患者继发免疫抑制的情况,他们接受了声门癌的放射治疗,并在治疗期间出现了多发性低颅神经麻痹,在60Gy时中断。还分析了可能的相关原因以及以前的免疫抑制治疗与放疗之间的关系,以阐明这种并发症的原因。
    The aim of the present study was to report an unusual case of multiple lower cranial nerve palsies in a patient with Wegener\'s granulomatosis (WG) during radiotherapy for glottic cancer. WG is an autoimmune disease characterized by necrotizing granulomas mainly in the upper and lower respiratory tract or kidneys; however, the involvement of cranial nerves is not uncommon. Prior to the use of cyclophosphamide (CYC) the 1-year mortality rate was ~82%; the introduction of rituximab (RTX) has revolutionized the course of the WG, with remission rates comparable to those of CYC and superior effectiveness in relapsing patients. Hypogammaglobulinemia and B-cell depletion are the best known monitored side effects affecting survival due to secondary infections. Immunodepression and relapse with lower cranial nerve palsy have a negative impact on prognosis. We herein present the case of a heavily pre-treated GPA patient with secondary immunosuppression, who underwent radiotherapy for glottic cancer and developed multiple low cranial nerve palsies during treatment, which was interrupted at 60 Gy. The possible related causes and the association between previous immunosuppressive treatments and radiotherapy were also analyzed to elucidate the cause of this complication.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Sci-hub)

       PDF(Pubmed)

  • 文章类型: Case Reports
    Various mechanisms such as second primary lesion, tumour seeding or lymphogenous and haematogenous metastasis could be proposed to explain the nature of dual malignant lesions. We report the case of a glottic laryngeal carcinoma combined with a secondary endotracheal tumour. Following the imaging modalities, the patient underwent total laryngectomy and wide excision of the trachea. Histopathology ultimately established that the tracheal lesion was a metastatic tumour secondary to regional lymphatic spread of the glottic tumour. To our knowledge, there is no previous report in the English literature concerning tracheal lymphogenous metastatic involvement in the context of laryngeal malignancy. Paradoxical lymphatic spread must always remain an issue of head and neck oncology.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Sci-hub)

       PDF(Pubmed)

  • 文章类型: Comparative Study
    To identify and compare treatment and system factors associated with survival in early-stage glottic cancer.
    Retrospective study of cases in the Commission on Cancer National Cancer Database.
    Adult patients with early glottic cancer (stage I or II) diagnosed between January 1, 2004, and December 31, 2012, were included. Demographic, tumor, and survival variables were included in the analyses. Multivariate Cox regressions as well as univariate Kaplan-Meier analyses were conducted.
    In total, 5,627 patients were included in the study. Treatment factors associated with improved survival included larynx-preserving surgery alone (hazard ratio [HR] 0.740; P = 0.001) and larynx-preserving surgery with radiation (HR 0.837; P = 0.010) when compared to radiotherapy alone. System factors associated with worse survival included intermediate- (HR 1.123; P = 0.047) or low- (HR 1.458; P = 0.017) volume centers; Medicaid (HR 1.882; P < 0.001), Medicare (HR 1.532; P < 0.001), or other government insurance (HR 2.041; P < 0.001); and delay between diagnosis and treatment greater than 100 days (HR 1.605; P = 0.006).
    A number of treatment and system factors were found to be significantly associated with survival when controlling for patient and tumor factors. These may present targets for the improvement of outcomes in early-stage glottic cancers.
    4. Laryngoscope, 127:616-622, 2017.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Sci-hub)

  • 文章类型: Journal Article
    Radiation therapy (RT) and endolaryngeal surgery are standard treatments for early-stage glottic cancer. They have closely matched oncological outcomes; however, it is debatable which method is superior in terms of functional outcomes. Several dosimetric studies have demonstrated that, compared with conventional RT, intensity-modulated RT (IMRT) reduces unnecessary radiation of the adjacent normal tissues, including the carotid artery and thyroid gland. However, RT targets the whole larynx, whereas endolaryngeal surgery is a highly focused treatment involving the en bloc resection of a tumor with safety margins. For T1a glottic cancer, in which the tumor is limited to one vocal cord, the technical feasibility of targeting IMRT on the single vocal cord affected has been investigated; however, the clinical feasibility and the possibility of inferior local control remain to be elucidated. In the present case study, IMRT was used to treat the whole larynx first, and then to treat a single vocal cord. The patient in the present study had T1a glottic cancer, and received volumetric modulated arc therapy with a total dose of 63 Gy/28 fractions. The first treatment phase (40.5 Gy/18 fractions) targeted the whole larynx to eliminate subclinical disease. The second treatment phase (22.5 Gy/10 fractions) targeted only the involved vocal cord. During this treatment phase, the exposure of the non-involved right vocal cord, the right carotid artery and the thyroid gland to the radiation was lower compared with the continuation of the initial treatment approach. These findings suggested that changing the target volume from the whole larynx to the affected vocal cord during the course of IMRT is feasible for T1a glottic cancer, and that it may reduce functional side effects while maintaining oncological outcomes.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

公众号